134 related articles for article (PubMed ID: 36695485)
1. COVID-19 mortality attenuated during widespread Omicron transmission, Denmark, 2020 to 2022.
Friis NU; Martin-Bertelsen T; Pedersen RK; Nielsen J; Krause TG; Andreasen V; Vestergaard LS
Euro Surveill; 2023 Jan; 28(3):. PubMed ID: 36695485
[TBL] [Abstract][Full Text] [Related]
2. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
[TBL] [Abstract][Full Text] [Related]
3. No excess mortality among working-age Italians during the Omicron wave of Covid-19.
Alicandro G; Remuzzi G; Centanni S; Gerli A; La Vecchia C
Med Lav; 2022 Jun; 113(3):e2022030. PubMed ID: 35766642
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021.
Espenhain L; Funk T; Overvad M; Edslev SM; Fonager J; Ingham AC; Rasmussen M; Madsen SL; Espersen CH; Sieber RN; Stegger M; Gunalan V; Wilkowski B; Larsen NB; Legarth R; Cohen AS; Nielsen F; Lam JUH; Lavik KE; Karakis M; Spiess K; Marving E; Nielsen C; Wiid Svarrer C; Bybjerg-Grauholm J; Olsen SS; Jensen A; Krause TG; Müller L
Euro Surveill; 2021 Dec; 26(50):. PubMed ID: 34915977
[TBL] [Abstract][Full Text] [Related]
5. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
COVID-19 Cumulative Infection Collaborators
Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
[TBL] [Abstract][Full Text] [Related]
6. Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods - United States, April 2020-June 2022.
Adjei S; Hong K; Molinari NM; Bull-Otterson L; Ajani UA; Gundlapalli AV; Harris AM; Hsu J; Kadri SS; Starnes J; Yeoman K; Boehmer TK
MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(37):1182-1189. PubMed ID: 36107788
[TBL] [Abstract][Full Text] [Related]
7. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
8. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
9. Mortality associated with Omicron and influenza infections in France before and during the COVID-19 pandemic.
Goldstein E
Epidemiol Infect; 2023 Aug; 151():e148. PubMed ID: 37622317
[TBL] [Abstract][Full Text] [Related]
10. Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.
New York City Department of Health and Mental Hygiene (DOHMH) COVID-19 Response Team
MMWR Morb Mortal Wkly Rep; 2020 May; 69(19):603-605. PubMed ID: 32407306
[TBL] [Abstract][Full Text] [Related]
11. Has Omicron Changed the Evolution of the Pandemic?
Lundberg AL; Lorenzo-Redondo R; Ozer EA; Hawkins CA; Hultquist JF; Welch SB; Prasad PVV; Oehmke JF; Achenbach CJ; Murphy RL; White JI; Havey RJ; Post LA
JMIR Public Health Surveill; 2022 Jan; 8(1):e35763. PubMed ID: 35072638
[TBL] [Abstract][Full Text] [Related]
12. Household transmission of the SARS-CoV-2 Omicron variant in Denmark.
Lyngse FP; Mortensen LH; Denwood MJ; Christiansen LE; Møller CH; Skov RL; Spiess K; Fomsgaard A; Lassaunière R; Rasmussen M; Stegger M; Nielsen C; Sieber RN; Cohen AS; Møller FT; Overvad M; Mølbak K; Krause TG; Kirkeby CT
Nat Commun; 2022 Sep; 13(1):5573. PubMed ID: 36151099
[TBL] [Abstract][Full Text] [Related]
13. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
COVID-19 Excess Mortality Collaborators
Lancet; 2022 Apr; 399(10334):1513-1536. PubMed ID: 35279232
[TBL] [Abstract][Full Text] [Related]
14. Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates.
Lundberg AL; Lorenzo-Redondo R; Hultquist JF; Hawkins CA; Ozer EA; Welch SB; Prasad PVV; Achenbach CJ; White JI; Oehmke JF; Murphy RL; Havey RJ; Post LA
JMIR Public Health Surveill; 2022 Jun; 8(6):e37377. PubMed ID: 35500140
[TBL] [Abstract][Full Text] [Related]
15. Emergence of SARS-CoV-2 Omicron variant and strategies for tackling the infection.
Wu Y; Long Y; Wang F; Liu W; Wang Y
Immun Inflamm Dis; 2022 Dec; 10(12):e733. PubMed ID: 36444634
[TBL] [Abstract][Full Text] [Related]
16. Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland.
Portmann L; de Kraker MEA; Fröhlich G; Thiabaud A; Roelens M; Schreiber PW; Troillet N; Iten A; Widmer A; Harbarth S; Sommerstein R;
JAMA Netw Open; 2023 Feb; 6(2):e2255599. PubMed ID: 36790812
[TBL] [Abstract][Full Text] [Related]
17. Recent insights into SARS-CoV-2 omicron variant.
Silva SJRD; Kohl A; Pena L; Pardee K
Rev Med Virol; 2023 Jan; 33(1):e2373. PubMed ID: 35662313
[TBL] [Abstract][Full Text] [Related]
18. Changes in all-cause and cause-specific excess mortality before and after the Omicron outbreak of COVID-19 in Hong Kong.
Chong KC; Chan PK; Hung CT; Wong CK; Xiong X; Wei Y; Zhao S; Guo Z; Wang H; Yam CH; Chow TY; Li C; Jiang X; Leung SY; Kwok KL; Yeoh EK; Li K
J Glob Health; 2023 Apr; 13():06017. PubMed ID: 37114968
[TBL] [Abstract][Full Text] [Related]
19. Multilayer factors associated with excess all-cause mortality during the omicron and non-omicron waves of the COVID-19 pandemic: time series analysis in 29 countries.
Zou F; Xiao J; Jin Y; Jian R; Hu Y; Liang X; Ma W; Zhu S
BMC Public Health; 2024 Feb; 24(1):350. PubMed ID: 38308279
[TBL] [Abstract][Full Text] [Related]
20. Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
Post LA; Benishay ET; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh LN; White J; Chaudhury AS; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Feb; 23(2):e25799. PubMed ID: 33475513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
